Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03544723
Title Safety and Efficacy of Ad-p53 in Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MultiVir, Inc.
Indications

head and neck squamous cell carcinoma

Therapies

Nivolumab

Ad5CMV-p53 gene + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.